Investigating new treatments for colon cancer in U.S. Veterans
Official title: BLRD Research Career Scientist Award Application
Funded at Omaha VA Medical Center · NIH-10951546 · Data updated 2026-11-12
This study is looking at how colon cancer grows and spreads, especially in U.S. Veterans who are more likely to get this disease, with the hope of finding new treatments that can help them live better and longer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Omaha VA Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | October 1, 2023 |
| Project end | September 30, 2028 |
| Funding year | 2025 |
| NIH project number | 5IK6BX006481-02 |
| Project ID | NIH-10951546 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are U.S. Veterans diagnosed with colon cancer, particularly those experiencing progression or metastasis of the disease.
✕Less likely to help
Patients who do not have colon cancer or are not Veterans may not receive any benefit from this research.
What this research studies
This research focuses on understanding the molecular mechanisms that contribute to colon cancer progression and metastasis, particularly in U.S. Veterans who are at a higher risk for this disease. The project aims to identify key proteins involved in these processes and develop targeted therapies that could improve survival rates and quality of life for affected patients. The research includes both preclinical and clinical studies, leveraging the lab's expertise in the role of specific proteins, such as Claudins, in cancer biology. By characterizing these mechanisms, the goal is to create innovative treatment strategies that address the unique needs of Veterans diagnosed with colon cancer.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments that significantly improve survival and quality of life for Veterans with colon cancer.
How similar studies have gone: Previous research has shown promise in targeting specific proteins involved in cancer progression, indicating that this approach could yield significant advancements in treatment.
Where this research is happening
-
Omaha VA Medical Center
Omaha, United States Active
Researchers
- Principal investigator: Dhawan, Punita — Omaha VA Medical Center
- Study coordinator: Dhawan, Punita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.